Reply to letter to editor “Hepatic irAEs, ICI Continuation, and Survival: Methodological Perspectives and Future Directions”

Hepatology International 2026

View at publisher

Authors: Tatsuo Kanda, Kaori Matsumoto, Shuntaro Obi, Hitoshi Mochizuki, Masao Omata

DOI: 10.1007/s12072-026-11034-2

Cited by: 0

References: 6

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Hepatocellular Carcinoma Treatment and Prognosis Pharmacovigilance and Adverse Drug Reactions

References 6